BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29620097)

  • 1. Structure-based design of targeted covalent inhibitors.
    Lonsdale R; Ward RA
    Chem Soc Rev; 2018 Jun; 47(11):3816-3830. PubMed ID: 29620097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress with covalent small-molecule kinase inhibitors.
    Zhao Z; Bourne PE
    Drug Discov Today; 2018 Mar; 23(3):727-735. PubMed ID: 29337202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of novel irreversible inhibitors for human arginase.
    Guo X; Chen Y; Seto CT
    Bioorg Med Chem; 2018 Aug; 26(14):3939-3946. PubMed ID: 29914772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Protein-Protein Interaction with Covalent Small-Molecule Inhibitors.
    Li B; Rong D; Wang Y
    Curr Top Med Chem; 2019; 19(21):1872-1876. PubMed ID: 31696799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Screening and Design for Compounds that Disrupt Protein-protein Interactions.
    Johnson DK; Karanicolas J
    Curr Top Med Chem; 2017; 17(23):2703-2714. PubMed ID: 28482793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
    Guo W; Wisniewski JA; Ji H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Covalent Inhibitors for Drug Design.
    Baillie TA
    Angew Chem Int Ed Engl; 2016 Oct; 55(43):13408-13421. PubMed ID: 27539547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing Irreversible Inhibitors--Worth the Effort?
    González-Bello C
    ChemMedChem; 2016 Jan; 11(1):22-30. PubMed ID: 26593241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-protein interactions: developing small-molecule inhibitors/stabilizers through covalent strategies.
    Lucero B; Francisco KR; Liu LJ; Caffrey CR; Ballatore C
    Trends Pharmacol Sci; 2023 Jul; 44(7):474-488. PubMed ID: 37263826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic Optimization of Lysine-Targeting Covalent Inhibitors of HSP72.
    Pettinger J; Carter M; Jones K; Cheeseman MD
    J Med Chem; 2019 Dec; 62(24):11383-11398. PubMed ID: 31725295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Cysteine-targeting Covalent Protein Kinase Inhibitors.
    Lu X; Smaill JB; Patterson AV; Ding K
    J Med Chem; 2022 Jan; 65(1):58-83. PubMed ID: 34962782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CovaDOTS: In Silico Chemistry-Driven Tool to Design Covalent Inhibitors Using a Linking Strategy.
    Hoffer L; Saez-Ayala M; Horvath D; Varnek A; Morelli X; Roche P
    J Chem Inf Model; 2019 Apr; 59(4):1472-1485. PubMed ID: 30908019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the Catalytic Power of Glutamate Racemase by Investigating a Series of Covalent Inhibitors.
    Vance NR; Witkin KR; Rooney PW; Li Y; Pope M; Spies MA
    ChemMedChem; 2018 Dec; 13(23):2514-2521. PubMed ID: 30264520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Electrophiles and Strategies for Mechanism-Based and Targeted Covalent Inhibitor Design.
    Ray S; Murkin AS
    Biochemistry; 2019 Dec; 58(52):5234-5244. PubMed ID: 30990686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted covalent drugs of the kinase family.
    Singh J; Petter RC; Kluge AF
    Curr Opin Chem Biol; 2010 Aug; 14(4):475-80. PubMed ID: 20609616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking-based virtual screening of covalently binding ligands: an orthogonal lead discovery approach.
    Schröder J; Klinger A; Oellien F; Marhöfer RJ; Duszenko M; Selzer PM
    J Med Chem; 2013 Feb; 56(4):1478-90. PubMed ID: 23350811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based Drug Design Strategies and Challenges.
    Wang X; Song K; Li L; Chen L
    Curr Top Med Chem; 2018; 18(12):998-1006. PubMed ID: 30101712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of small molecule sphingomyelin synthase inhibitors.
    Deng X; Lin F; Zhang Y; Li Y; Zhou L; Lou B; Li Y; Dong J; Ding T; Jiang X; Wang R; Ye D
    Eur J Med Chem; 2014 Feb; 73():1-7. PubMed ID: 24374347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of covalent inhibitors of glyceraldehyde-3-phosphate dehydrogenase, a target for the treatment of malaria.
    Bruno S; Pinto A; Paredi G; Tamborini L; De Micheli C; La Pietra V; Marinelli L; Novellino E; Conti P; Mozzarelli A
    J Med Chem; 2014 Sep; 57(17):7465-71. PubMed ID: 25137375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicomponent Reactions.
    Cimarelli C
    Molecules; 2019 Jun; 24(13):. PubMed ID: 31252514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.